In the media
News
Partner news
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Read full storyIn the media
Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland
Read full storyIn the media
BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs
Read full storyIn the media
As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on
Read full storyPartner news
Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease
Read full storyPartner news
Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.
Read full storyPartner news
Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Bpifrance to Accelerate Innovations in the Field of Sleep Science
Read full storyJNJ Press releases
Zebra Medical Vision raises $30 million
Read full storyIn the media